Second Interim Analysis of Clinical Outcomes After 135 Patients Results in Recommendation to Continue Remestemcel-L Phase 3 Trial in COVID-19 ARDS

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing